? CANCER AND PHYSICAL SCIENCES The Cancer and Physical Sciences (CAPS) program capitalizes on the unique strengths and international leadership of Northwestern University in nanotechnology and physical sciences. The program brings together fundamental chemistry, nano-technology, imaging, and bioengineering groups to develop cancer-relevant therapeutic and diagnostic agents using nanoscale materials and physical sciences approaches. The resulting synergies have been leveraged by the Lurie Cancer Center (LCC) into the NCI-funded Center for Cancer Nanotechnology Excellence (CCNE) and the NCI-funded Physical Sciences in Oncology Center (PSOC). The CAPS Program received ?Exceptional to Outstanding? merit at the last CCSG renewal application. Since then the program has been further strengthened by enhancing the integration of engineering and physical sciences investigators within the arena of cancer research, developing new strategies and technologies that facilitate efficient interactions among program members and by accelerating translational efforts. Vadim Backman, PhD, a bioengineer, is the Program Leader, and Gayle Woloschak, PhD, a biochemist and molecular biologist, is the Program Co-Leader. This uniquely interdisciplinary program comprises 28 faculty members from 11 departments and 3 schools. Between 2013 and 2017 there have been 417 cancer-relevant publications from the program members. Sixty-eight (16%) of these publications represent intra-programmatic collaborations, 87 (21%) represent inter-programmatic collaborations, and 207 (50%) represent external collaborative publications. 154 (37%) of the publications were in high impact (>9) journals. Current cancer-relevant funding is $12,212,040 (direct) in total peer-reviewed funding out of which $4,253,788 (direct) is from NCI. CAPS investigators focus on (1) the elucidation of fundamental mechanisms and molecular pathways that control oncogenesis by physical science methods, (2) the development of novel technologies for early cancer detection and (3) the discovery and development of nanotechnology- and physical sciences based tumor targeting agents and therapeutic modalities. Towards reaching these objectives, CAPS serves as a forum to link basic biological investigation with practical applications from the fields of chemistry, physics, engineering and nanotechnology. It provides webinars, symposia and financial awards to stimulate intra- and inter-programmatic collaborations on a broad spectrum of translational projects. CAPS has facilitated the creation of innovative tools for the diagnosis, detection, and treatment of cancer, including new imaging agents, a new technology for early cancer detection, and novel therapeutic modalities. A number of these developments have advanced from basic engineering research to clinical trials and clinical care. CAPS? future plans are designed to further accelerate discovery and translation within the LCC through faculty recruitment and bridge building, increasing opportunities for scientific exchange, and fostering partnerships with industry.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA060553-25
Application #
9762042
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
25
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Lewis, Phillip L; Green, Richard M; Shah, Ramille N (2018) 3D-printed gelatin scaffolds of differing pore geometry modulate hepatocyte function and gene expression. Acta Biomater 69:63-70
Ugolkov, Andrey V; Bondarenko, Gennadiy I; Dubrovskyi, Oleksii et al. (2018) 9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma. Anticancer Drugs 29:717-724
Chen, Charlotte H; Palmer, Liam C; Stupp, Samuel I (2018) Self-Repair of Structure and Bioactivity in a Supramolecular Nanostructure. Nano Lett 18:6832-6841
Volk, Andrew; Liang, Kaiwei; Suraneni, Praveen et al. (2018) A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis. Cancer Cell 34:707-723.e7
Graves, Stephen; Seagle, Brandon-Luke L; Kocherginsky, Masha et al. (2018) Scholarship Support for Veterans Enrolling in MD, JD, and MBA Programs. JAMA 320:1197-1198
Du, Jingshan S; Chen, Peng-Cheng; Meckes, Brian et al. (2018) Windowless Observation of Evaporation-Induced Coarsening of Au-Pt Nanoparticles in Polymer Nanoreactors. J Am Chem Soc 140:7213-7221
Gao, Ruoqi; Piguel, Nicolas H; Melendez-Zaidi, Alexandria E et al. (2018) CNTNAP2 stabilizes interneuron dendritic arbors through CASK. Mol Psychiatry 23:1832-1850
Greene, Jacqueline J; McClendon, Mark T; Stephanopoulos, Nicholas et al. (2018) Electrophysiological assessment of a peptide amphiphile nanofiber nerve graft for facial nerve repair. J Tissue Eng Regen Med 12:1389-1401
Stack, Trevor; Vahabikashi, Amir; Johnson, Mark et al. (2018) Modulation of Schlemm's canal endothelial cell stiffness via latrunculin loaded block copolymer micelles. J Biomed Mater Res A 106:1771-1779
Blair, Kris M; Mears, Kevin S; Taylor, Jennifer A et al. (2018) The Helicobacter pylori cell shape promoting protein Csd5 interacts with the cell wall, MurF, and the bacterial cytoskeleton. Mol Microbiol 110:114-127

Showing the most recent 10 out of 1972 publications